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Evaluation of CBD Supplementation in the Horse
Introduction and Objective
Project 1: Pilot
Passing the 2014 and 2018 Farm Bill Acts
stimulated interest in hemp and its
derivatives. Cannabidiol (CBD) is being
touted as a comprehensive treatment
option for a variety of human and animal
ailments. Currently, CBD products lack
fundamental research pertinent to
regulation of product quality and dosing
recommendations, particularly in equines
where it is frequently being used for
behavior modification. Three studies were
designed to better understand the effects of
CBD supplementation in horses.
 Current dosage recommendations for
horses (25-50 mg/d) based on small
animal dosage and may not be
appropriate on body weight basis
 Supplementation at lower doses may
be needed for several weeks before
effects seen on behavior in horses,
possible accumulation in tissues?
 Higher doses may have more
immediate effect on painful conditions
(neuropathy, arthritis?)
 Liver enzyme changes needs further
evaluation
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Methods
 Horse 1: single 50 mg dosage PEL
 Horse 2: single 50 mg dosage OIL
 Blood collected 1 and 2 hr post treatment
Results
 CBD not detected at standard lower limit
concentration of 1 ng/ml
 Detected at 0.05 ng/ml
Methods
 6 horses: single dosage 50 mg PEL
 6 horses: single dosage 100 mg PEL
 6 horses: single dosage 250 mg PEL
 Blood collected pre-treatment and
0.5, 1, 2, 4 and 12 hr post-treatment
Results
 250 mg dose consistently detected
at 1 ng/ml (n=5/6)
 Peak concentration and clearance
times similar to other species
 Changes in liver enzymes, but values
within normal ranges
Figure 1.  Serum CBD concentration (ng/ml) in 
horses fed a single 50 mg treatment of pellets
Figure 2. Pharmacokinetics of a single 250 
mg treatment of CBD pellets in horses
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Implications and Further Research
Methods
 12 horses: 100 mg PEL daily for 12 wk
 12 horses: 0 mg PEL
 Novel object reaction test
 Flexion and movement evaluations
 Blood pre-treatment and every 2 wk for
12 wk of supplementation
Project currently in progress.
Project 3: Behavior and Movement 
Figure 3. Novel object reaction test in horses 
before CBD supplementation
